Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedThe page now includes a government funding lapse notice indicating the NIH Clinical Center is open and operations may be affected, and the site version has been updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check9 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Deleted: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision label was updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check44 days agoChange DetectedLocations section added listing study sites across multiple states and Ontario. Revision updated to v3.3.3.SummaryDifference2%

- Check73 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no changes to study details or user-facing functionality were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedThe government funding status banner was removed from the page. Core study content remains unchanged.SummaryDifference0.3%

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.